PIDTC: Evaluating the Effects of Lentiviral Gene Therapy for Artemis-deficient Severe Combined Immunodeficiency
22 de feb. de 2023 ·
2m 4s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the New England Journal of Medicine on December 22, 2022, titled...
mostra más
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the New England Journal of Medicine on December 22, 2022, titled "Lentiviral Gene Therapy for Artemis-Deficient SCID."
Read the paper here: https://www.nejm.org/doi/10.1056/NEJMoa2206575
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
mostra menos
Read the paper here: https://www.nejm.org/doi/10.1056/NEJMoa2206575
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
Información
| Autor | RDCRN |
| Organización | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
